Ra Capital Management, L.P. sold $9.1M of LENZ Therapeutics (LENZ)

Executed Oct 29, disclosed Nov 2, 4 days later.

Value, as filed

$9.1M

2,718,684 sh across 3 lots

Executed

Oct 29

the trade date, as filed

Disclosed

Nov 2

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

RP Ra Capital Management, L.P. Director profile →

Ra Capital Management, L.P. (Director) filed 31 Form 4 reports as a reporting entity in the trailing twelve months (23 purchases, 8 sales, 1 filed past the two-business-day deadline), most often in Artiva Biotherapeutics, Inc. (ARTV). Across 22 priced purchase filings, the average 21-session return was +16.2% from execution and +14.2% from disclosure (delay-adjusted; derived). The largest single filing was $423.8M of PBLS (21,188,750 sh across 2 lots, as filed), executed Jun 11.

The name

LENZ LENZ Therapeutics, Inc. LENZ · Healthcare · 12 filings in 24 months ticker →

Healthcare · LENZ Therapeutics, Inc. operates as a commercial pharmaceutical company that focuses on the development and commercialization of therapies…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→